The immune microenvironment as an anti-cancer therapeutic strategy
The immune microenvironment as an anti-cancer therapeutic strategy
PETROC / OV21: Phase II/III trial of peritoneal treatment for ovarian cancer
The molecular basis of cancer
The role of molecular pathways in therapeutic response and outcomes in breast cancer
Future perspectives: realising the potential of personalised healthcare in gynaecological cancer
Updates on advances and trials from ASCO; geriatric oncology overview
Adverse effects of treatment on elderly patients
The revolution in personalised healthcare: Towards improved outcomes in oncology: Conclusion and Summary
Advances in geriatric, medical oncology
Results from the SIOG task force on geriatric assessment
Development of biosimilars for use in treating elderly patients
Results from the TRINOVA 1 trial